OTLK logo

Outlook Therapeutics (OTLK) Selling, General & Administrative Expenses

Annual SGA

$29.94 M
+$3.27 M+12.25%

September 30, 2024

Summary

Performance

1-Year Change

+12.25%

3-Year Change

+134.48%

5-Year Change

+219.54%

15-Year Change

+88.52%

OTLK SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

50.49%
OTLK annual SGA is higher than 50.49% of companies in Healthcare sector

High & Low

All-time High

$29.94 M
OTLK annual SGA is currently at an all-time high

3-Year Low

$12.77 M
OTLK annual SGA is currently +134.48% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2024
OTLK previous annual earnings announcement was published on Sep 30, 2024

Next Annual Earnings Report Date

N/A
OTLK next annual earnings announcement has not yet been scheduled

OtherOTLKexpensesmetrics:

Annual Total Expenses

$71.70 M
OTLK annual total expenses is $71.70 million

Annual Operating Expenses

$71.70 M
OTLK annual total operating expenses is $71.70 million

Annual Cost Of Goods Sold

-
OTLK annual cost of goods sold value is unknown

Annual Interest Expense

$3.16 M
OTLK annual interest expense is $3.16 million

Quarterly SGA

$10.35 M
+$1.99 M+23.84%

September 1, 2024

Summary

Performance

3-Month Change

+23.84%

1-Year Change

+78.72%

3-Year Change

+195.77%

5-Year Change

+429.04%

OTLK Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

54.48%
OTLK quarterly SGA is higher than 54.48% of companies in Healthcare sector

High & Low

All-time High

$10.50 M
OTLK quarterly SGA is currently -1.43% below its historical high of $10.50 million

3-Year Low

$3.28 M
OTLK quarterly SGA is currently +215.95% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
OTLK previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
OTLK next earnings announcement is scheduled for Feb 14, 2025

OtherOTLKexpensesmetrics:

Quarterly Total Expenses

$22.88 M
OTLK quarterly total expenses is $22.88 million

Quarterly Operating Expenses

$22.88 M
OTLK quarterly total operating expenses is $22.88 million

Quarterly Cost Of Goods Sold

-
OTLK quarterly cost of goods sold value is unknown

Quarterly Interest Expense

$0.00
OTLK quarterly interest expense is $0.00

TTM SGA

-$2.16 B
-$75.37 M-3.61%

September 1, 2024

Summary

Performance

3-Month Change

-8087.77%

1-Year Change

-8225.39%

3-Year Change

-17053.38%

5-Year Change

-24394.29%

OTLK TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

21.73%
OTLK TTM SGA is higher than 21.73% of companies in Healthcare sector

High & Low

All-time High

-$94.06 M

3-Year Low

-$2.16 B
OTLK TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
OTLK previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
OTLK next earnings announcement is scheduled for Feb 14, 2025

OtherOTLKexpensesmetrics:

Annual Total Expenses

$71.70 M
OTLK annual total expenses is $71.70 million

Annual Operating Expenses

$71.70 M
OTLK annual total operating expenses is $71.70 million

TTM Cost Of Goods Sold

-
OTLK TTM cost of goods sold value is unknown

TTM Interest Expense

$0.00
OTLK TTM interest expense is $0.00

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$29.94 M
OTLK annual SGA is $29.94 million

Annual Operating Expenses

$71.70 M
OTLK annual total operating expenses is $71.70 million

Annual Cost Of Goods Sold

-
OTLK annual cost of goods sold value is unknown

OTLK Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+12.3%+78.7%-8225.4%
3 y3 years+134.5%+195.8%-10000.0%
5 y5 years+219.5%+429.0%-10000.0%

OTLK Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+134.5%at high+215.9%-60.7%at low
5 y5-yearat high+219.5%at high+429.0%-114.3%at low
alltimeall timeat high+309.1%-1.4%+5566.9%-2201.3%at low

Outlook Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
$29.94 M(+12.2%)
-
-
Sep 2024
-
$10.35 M(+23.8%)
$29.94 M(+10.5%)
Jun 2024
-
$8.36 M(+53.9%)
$27.10 M(+5.1%)
Mar 2024
-
$5.43 M(-6.3%)
$25.78 M(-3.2%)
Dec 2023
-
$5.79 M(-22.9%)
$26.64 M(-0.1%)
Sep 2023
$26.67 M(+28.6%)
$7.51 M(+6.7%)
$26.67 M(+10.4%)
Jun 2023
-
$7.04 M(+11.9%)
$24.16 M(+5.5%)
Mar 2023
-
$6.29 M(+8.0%)
$22.89 M(-1.7%)
Dec 2022
-
$5.83 M(+16.6%)
$23.29 M(+12.3%)
Sep 2022
$20.74 M(+62.4%)
$5.00 M(-13.5%)
$20.74 M(+7.8%)
Jun 2022
-
$5.77 M(-13.7%)
$19.24 M(+17.4%)
Mar 2022
-
$6.69 M(+104.1%)
$16.40 M(+18.8%)
Dec 2021
-
$3.28 M(-6.4%)
$13.80 M(+8.1%)
Sep 2021
$12.77 M(+28.1%)
$3.50 M(+19.5%)
$12.77 M(+9.5%)
Jun 2021
-
$2.93 M(-28.5%)
$11.66 M(-3.0%)
Mar 2021
-
$4.10 M(+82.7%)
$12.02 M(+21.7%)
Dec 2020
-
$2.24 M(-6.2%)
$9.88 M(-0.9%)
Sep 2020
$9.97 M(+6.4%)
$2.39 M(-27.3%)
$9.97 M(-3.8%)
Jun 2020
-
$3.29 M(+67.9%)
$10.36 M(+16.3%)
Mar 2020
-
$1.96 M(-16.2%)
$8.91 M(+1.2%)
Dec 2019
-
$2.34 M(-16.0%)
$8.80 M(-6.1%)
DateAnnualQuarterlyTTM
Sep 2019
$9.37 M(-34.1%)
$2.78 M(+51.7%)
$9.37 M(-25.8%)
Jun 2019
-
$1.83 M(-0.8%)
$12.62 M(-2.8%)
Mar 2019
-
$1.85 M(-36.3%)
$12.99 M(-4.4%)
Dec 2018
-
$2.90 M(-51.9%)
$13.58 M(-4.5%)
Sep 2018
$14.23 M(-10.4%)
$6.04 M(+174.9%)
$14.23 M(+21.6%)
Jun 2018
-
$2.20 M(-10.2%)
$11.70 M(-9.9%)
Mar 2018
-
$2.45 M(-31.1%)
$12.99 M(-10.8%)
Dec 2017
-
$3.55 M(+1.2%)
$14.56 M(-8.3%)
Sep 2017
$15.88 M(-26.3%)
$3.51 M(+0.7%)
$15.88 M(-16.2%)
Jun 2017
-
$3.48 M(-13.5%)
$18.95 M(-27.0%)
Mar 2017
-
$4.02 M(-17.4%)
$25.97 M(+19.4%)
Dec 2016
-
$4.87 M(-25.9%)
$21.76 M(+0.9%)
Sep 2016
$21.56 M(+67.1%)
$6.57 M(-37.4%)
$21.56 M(+9.7%)
Jun 2016
-
$10.50 M(-5646.3%)
$19.66 M(+66.4%)
Mar 2016
-
-$189.40 K(-104.1%)
$11.81 M(-27.7%)
Dec 2015
-
$4.67 M(+0.2%)
$16.34 M(+26.6%)
Sep 2015
$12.91 M(+76.3%)
$4.67 M(+75.5%)
$12.91 M(+56.6%)
Jun 2015
-
$2.66 M(-38.7%)
$8.24 M(+47.7%)
Mar 2015
-
$4.34 M(+250.8%)
$5.58 M(+350.8%)
Dec 2014
-
$1.24 M
$1.24 M
Sep 2014
$7.32 M
-
-

FAQ

  • What is Outlook Therapeutics annual SGA?
  • What is the all time high annual SGA for Outlook Therapeutics?
  • What is Outlook Therapeutics annual SGA year-on-year change?
  • What is Outlook Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Outlook Therapeutics?
  • What is Outlook Therapeutics quarterly SGA year-on-year change?
  • What is Outlook Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Outlook Therapeutics?
  • What is Outlook Therapeutics TTM SGA year-on-year change?

What is Outlook Therapeutics annual SGA?

The current annual SGA of OTLK is $29.94 M

What is the all time high annual SGA for Outlook Therapeutics?

Outlook Therapeutics all-time high annual SGA is $29.94 M

What is Outlook Therapeutics annual SGA year-on-year change?

Over the past year, OTLK annual SGA has changed by +$3.27 M (+12.25%)

What is Outlook Therapeutics quarterly SGA?

The current quarterly SGA of OTLK is $10.35 M

What is the all time high quarterly SGA for Outlook Therapeutics?

Outlook Therapeutics all-time high quarterly SGA is $10.50 M

What is Outlook Therapeutics quarterly SGA year-on-year change?

Over the past year, OTLK quarterly SGA has changed by +$4.56 M (+78.72%)

What is Outlook Therapeutics TTM SGA?

The current TTM SGA of OTLK is -$2.16 B

What is the all time high TTM SGA for Outlook Therapeutics?

Outlook Therapeutics all-time high TTM SGA is -$94.06 M

What is Outlook Therapeutics TTM SGA year-on-year change?

Over the past year, OTLK TTM SGA has changed by -$2.19 B (-8225.39%)